143 related articles for article (PubMed ID: 16084097)
1. Synthesis and evaluation of a DHA and 10-hydroxycamptothecin conjugate.
Wang Y; Li L; Jiang W; Larrick JW
Bioorg Med Chem; 2005 Oct; 13(19):5592-9. PubMed ID: 16084097
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and preliminary anticancer evaluation of 10-hydroxycamptothecin analogs.
Yu P; Xia L; Zhao J; Zhang G; Zhang Z; Lang M; Wang Y
Biol Pharm Bull; 2012; 35(8):1295-9. PubMed ID: 22863928
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.
Kingsbury WD; Boehm JC; Jakas DR; Holden KG; Hecht SM; Gallagher G; Caranfa MJ; McCabe FL; Faucette LF; Johnson RK
J Med Chem; 1991 Jan; 34(1):98-107. PubMed ID: 1846923
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and preliminary antitumor activity evaluation of a DHA and doxorubicin conjugate.
Wang Y; Li L; Jiang W; Yang Z; Zhang Z
Bioorg Med Chem Lett; 2006 Jun; 16(11):2974-7. PubMed ID: 16563756
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of CBI-bearing ester and carbamate prodrugs of CC-1065 analogue.
Wang Y; Li L; Tian Z; Jiang W; Larrick JW
Bioorg Med Chem; 2006 Dec; 14(23):7854-61. PubMed ID: 16908174
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity of 20(S)-camptothecin derivatives: A-ring modified and 7,10-disubstituted camptothecins.
Sawada S; Matsuoka S; Nokata K; Nagata H; Furuta T; Yokokura T; Miyasaka T
Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3183-8. PubMed ID: 1814610
[TBL] [Abstract][Full Text] [Related]
7. Cyclane-aminol 10-hydroxycamptothecin analogs as novel DNA topoisomerase I inhibitors induce apoptosis selectively in tumor cells.
Zhang S; Geng T; Jiang B; Song G; Ha L; Sun C; Qian Y; Fan Q; Guo H
Anticancer Drugs; 2014 Jul; 25(6):614-23. PubMed ID: 24525588
[TBL] [Abstract][Full Text] [Related]
8. Novel colon-specific microspheres with highly dispersed hydroxycamptothecin cores: their preparation, release behavior, and therapeutic efficiency against colonic cancer.
Lu B; Zhang Z
J Pharm Sci; 2006 Dec; 95(12):2619-30. PubMed ID: 16917869
[TBL] [Abstract][Full Text] [Related]
9. Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties.
Lesueur-Ginot L; Demarquay D; Kiss R; Kasprzyk PG; Dassonneville L; Bailly C; Camara J; Lavergne O; Bigg DC
Cancer Res; 1999 Jun; 59(12):2939-43. PubMed ID: 10383158
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biological Evaluation of Novel Water-Soluble Poly-(ethylene glycol)-10-hydroxycamptothecin Conjugates.
Guo N; Jiang D; Wang L; You X; Teng YO; Yu P
Molecules; 2015 May; 20(5):9393-404. PubMed ID: 26007190
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
12. Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues.
Lavergne O; Lesueur-Ginot L; Pla Rodas F; Kasprzyk PG; Pommier J; Demarquay D; Prévost G; Ulibarri G; Rolland A; Schiano-Liberatore AM; Harnett J; Pons D; Camara J; Bigg DC
J Med Chem; 1998 Dec; 41(27):5410-9. PubMed ID: 9876111
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effects of low-dose 10-hydroxycamptothecin in human colon cancer.
Ping YH; Lee HC; Lee JY; Wu PH; Ho LK; Chi CW; Lu MF; Wang JJ
Oncol Rep; 2006 May; 15(5):1273-9. PubMed ID: 16596197
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antitumor activity, and mechanism of action of benzo[b]chromeno[6,5-g][1,8]naphthyridin-7-one analogs of acronycine.
Tian W; Yougnia R; Depauw S; Lansiaux A; David-Cordonnier MH; Pfeiffer B; Kraus-Berthier L; Léonce S; Pierré A; Dufat H; Michel S
J Med Chem; 2014 Dec; 57(24):10329-42. PubMed ID: 25360689
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxic activity of acronycine derivatives modified at the pyran ring.
Elomri A; Skaltsounis AL; Michel S; Tillequin F; Koch M; Rolland Y; Pierré A; Atassi G
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2165-8. PubMed ID: 8945782
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and antiproliferative activity of some new azapyranoxanthenone aminoderivatives.
Kolokythas G; Pouli N; Marakos P; Pratsinis H; Kletsas D
Eur J Med Chem; 2006 Jan; 41(1):71-9. PubMed ID: 16300857
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of 9-acyloxyellipticines.
Harada N; Ozaki K; Oda K; Nakanishi N; Ohashi M; Hashiyama T; Tsujihara K
Chem Pharm Bull (Tokyo); 1997 Jul; 45(7):1156-62. PubMed ID: 9246749
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of ring A- and F-modified hexacyclic camptothecin analogues.
Sugimori M; Ejima A; Ohsuki S; Uoto K; Mitsui I; Kawato Y; Hirota Y; Sato K; Terasawa H
J Med Chem; 1998 Jun; 41(13):2308-18. PubMed ID: 9632364
[TBL] [Abstract][Full Text] [Related]
19. Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
Siddiqui RA; Harvey KA; Xu Z; Natarajan SK; Davisson VJ
Bioorg Med Chem; 2014 Mar; 22(6):1899-908. PubMed ID: 24556504
[TBL] [Abstract][Full Text] [Related]
20. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.
Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X
Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
